India To Raise Drug-Access Issue In Bilateral Talks With Japan
This article was originally published in PharmAsia News
Executive Summary
The Indian government plans to raise ease-of-access issues with its Japanese counterpart on behalf of India's pharmaceutical industry. Indian pharmas have complained that Japanese are hesitant to sell Indian drugs, leaving the companies to circumvent the blockage by hiring Chinese or South Korean agents in Japan. The two nations have scheduled a meeting to discuss a comprehensive economic partnership agreement between the two countries. The head of the Indian Drug Manufacturers' Association, Ashok Kumar, said Japan also has different specifications for drugs, causing a translation problem that leads to rejections. (Click here for more